Search
Newsletters
Editions
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Olivia Goldhill - Quartz
Psychedelic treatment for depression is on sale for the first time
The business interests behind vaccine trials work against people of color
VIP patients don’t always get the best medical treatment
UK scientists are pushing for the world’s first coronavirus challenge trials
With every reversal of Covid-19 guidance, the CDC is losing the battle for public trust
When AI in healthcare goes wrong, who is responsible?
US freezers aren’t cold enough to store one major coronavirus vaccine
The number of uninsured Americans was up even before the pandemic
The disproportionate mental health effects of Covid-19 on Black and Latino populations
Covid-19 vaccines could be distributed through churches, beauty salons, and poultry farms
Scientists are trying to explain why so few Kenyans are dying of coronavirus
Healthcare experts debate whether to hand out vaccines based on race
The pandemic is making women reconsider when and if to have babies
The UK tested a classic psychological tactic by paying 64 million restaurant bills
Wall Street donors are racing to back psychedelic therapy
Australia won’t be the last country to wrestle with a mandatory coronavirus vaccine
It could take 8,000 cargo plane loads to ship Covid-19 vaccines around the world
Once US healthcare workers get a coronavirus vaccine, who will be next?
All of medicine should be paying reparations to Henrietta Lacks
Ketamine’s promise as an antidepressant is being undermined by its lack of profit
More stories